Dr.ย Seeย Hui Ti
MB.ChB, MRCP (UK), FRCP (Edinburgh), FAMS (Medical Oncology)
Senior Consultant Medical Oncologist
corporate_fareParkway Cancer Centre, Singapore
See Hui Ti
MB.ChB, MRCP (UK), FRCP (Edinburgh), FAMS (Medical Oncology)
Dr. See Hui Ti is a Senior Consultant Medical Oncologist at Parkway Cancer Centre, Singapore, with a focused clinical expertise in adult breast cancer and gynaecological cancers. Her qualifications include MB.ChB (Leicester, UK), MRCP (United Kingdom), FRCP (Edinburgh), and FAMS (Medical Oncology).
Dr. See's career has been shaped by training across the United Kingdom, Singapore, and the United States. After registering with the General Medical Council in the UK in 1996 and working at Queen Elizabeth Hospital in Birmingham, she continued her medical training at Singapore General Hospital and completed advanced oncology training at the National Cancer Centre Singapore. She was awarded the Singapore Government HMDP Fellowship in 2002 and subsequently undertook further medical oncology training at M.D. Anderson Cancer Center in Houston, Texas, from 2003 to 2004. Prior to joining Parkway Cancer Centre, she served as a Consultant in Medical Oncology at the National Cancer Centre Singapore and as a Visiting Consultant at KK Women's and Children's Hospital, with a clinical emphasis on adult breast and gynaecologic cancers. She has also served on the executive committee of the Singapore Society of Oncology and is a member of the International Gynecologic Cancer Society and the American Society of Clinical Oncology.
CancerFax can coordinate medical-report review and consultation support for international patients seeking a specialist opinion from Dr. See Hui Ti at Parkway Cancer Centre, Singapore.
Why Consider Dr. See Hui Ti?
Dr. See Hui Ti brings a focused subspecialty practice in breast and gynaecological cancers, backed by advanced training at leading institutions across Singapore, the United Kingdom, and the United States.
Areas of Specialisation
Focused medical oncology expertise in breast cancer and gynaecological malignancies
Dr. See Hui Ti's clinical practice centres on the systemic treatment of adult breast cancer and gynaecological cancers. Her work spans treatment planning, chemotherapy, targeted therapy, cancer risk assessment, and multidisciplinary coordination for women's cancers.
Breast Cancer โ Medical Oncology
Systemic treatment planning and advanced care for breast cancer across all stages.
- arrow_rightChemotherapy regimens for curative intent
- arrow_rightHormonal therapy and targeted agent integration
- arrow_rightNeoadjuvant and adjuvant treatment planning
- arrow_rightSystemic treatment planning for stage 4 disease
- arrow_rightTargeted therapy options where biomarker profile supports
- arrow_rightLong-term disease management and monitoring
- arrow_rightMultigene testing discussion for hereditary breast and ovarian cancer risk
- arrow_rightRisk-based assessment and clinical guidance
Gynaecological Cancers
Medical oncology care for ovarian, cervical, and other gynaecological malignancies.
- arrow_rightChemotherapy and systemic treatment planning for ovarian cancer
- arrow_rightMaintenance therapy and monitoring strategies
- arrow_rightSystemic treatment for cervical cancer
- arrow_rightMultidisciplinary coordination with surgical and radiation oncology teams
Procedures Performed
Clinical services and systemic treatment approaches
Dr. See Hui Ti provides medical oncology consultations and systemic treatment planning for breast and gynaecological cancers, including assessment of treatment options, coordination with treating teams, cancer risk evaluation, and specialist second-opinion services.
Systemic Cancer Treatment
Medical OncologyPlanning and oversight of systemic treatment for breast and gynaecological cancers across disease stages.
Targeted and Biomarker-Driven Therapy
Targeted TherapyTargeted treatment planning based on tumour biology and biomarker profile.
Cancer Risk Assessment
DiagnosisRisk evaluation and multigene testing discussion for women at elevated hereditary cancer risk.
Second Opinion
Second OpinionSpecialist review of breast and gynaecological cancer cases for patients seeking additional clinical perspective.
Research & Publications
Academic contributions in breast and gynaecological oncology
Dr. See Hui Ti's academic focus is on breast cancer and gynaecological cancers. She has contributed patient-facing educational content on breast cancer diagnosis and treatment, metastatic disease management, and multigene testing for hereditary cancer risk, published through Parkway Cancer Centre.
A verified list of Dr. See Hui Ti's peer-reviewed publications will be added once confirmed through PubMed and institutional publication sources.
Education & Training
Dr. See Hui Ti completed her medical degree in the United Kingdom and trained across Singapore and the United States. Her postgraduate qualifications include MRCP (United Kingdom), FRCP (Edinburgh), and FAMS (Medical Oncology).
Clinical Experience
Dr. See Hui Ti has built her career across leading oncology institutions in the United Kingdom, Singapore, and the United States. She currently serves as Senior Consultant Medical Oncologist at Parkway Cancer Centre, Singapore.
Languages & International
Dr. See Hui Ti consults in English and Mandarin. Her clinic listing at Mount Elizabeth Medical Centre also includes Hokkien, Cantonese, and Teochew as available communication languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting Dr. See Hui Ti.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. See Hui Ti
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. See Hui Ti's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. See Hui Ti's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. See Hui Ti before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. See Hui Ti's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. See Hui Ti's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. See Hui Ti's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. See Hui Ti
Dr. See Hui Ti is a Senior Consultant Medical Oncologist at Parkway Cancer Centre, Singapore, specialising in adult breast cancer and gynaecological cancers including ovarian and cervical cancers. She holds qualifications including MB.ChB (Leicester, UK), MRCP (United Kingdom), FRCP (Edinburgh), and FAMS (Medical Oncology).
Dr. See Hui Ti specialises in adult breast cancer and gynaecological cancers. Her clinical focus includes early, locally advanced, and metastatic breast cancer, ovarian cancer, cervical cancer, and other gynaecological malignancies. She also provides guidance on hereditary cancer risk assessment and multigene testing for women at elevated genetic risk.
Dr. See Hui Ti is a Senior Consultant at Parkway Cancer Centre in Singapore. She sees patients at Mount Elizabeth Medical Centre and Mount Elizabeth Novena Specialist Centre. CancerFax can help international patients prepare reports and coordinate consultation requests.
CancerFax can coordinate medical-report review and consultation support for international patients seeking a specialist opinion from Dr. See Hui Ti at Parkway Cancer Centre, subject to hospital availability and case acceptance. Patients may submit their reports through CancerFax for initial review and case preparation.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case summary, and coordinate the next steps with Parkway Cancer Centre, subject to availability and case suitability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant investigation results. The final consultation format and availability depend on Parkway Cancer Centre's schedule and the nature of the case.
Connect with See Hui Ti Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.